Consequently, focusing on ACSS2 may offer cutting-edge methods for treating tumours and ACSS2 inhibitors can be effective in halting cancer growth and can be combined with other antineoplastic drugs to reduce drug resistance [6]. This evidence concerns the gene ACSS2 and neoplasm.